Shares of PureTech Health plc (NASDAQ:PRTC – Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $25.00, but opened at $23.27. PureTech Health shares last traded at $23.51, with a volume of 2,099 shares changing hands.
PureTech Health Trading Down 6.7 %
The stock’s 50-day simple moving average is $28.21 and its 200 day simple moving average is $26.35.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in PureTech Health stock. AWM Investment Company Inc. acquired a new stake in shares of PureTech Health plc (NASDAQ:PRTC – Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 6,900 shares of the company’s stock, valued at approximately $197,000. 0.04% of the stock is currently owned by institutional investors and hedge funds.
PureTech Health Company Profile
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Featured Articles
- Five stocks we like better than PureTech Health
- Pros And Cons Of Monthly Dividend Stocks
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- How to Calculate Return on Investment (ROI)
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- What Are Dividend Contenders? Investing in Dividend Contenders
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
